Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease

Affiliations

• ¹ Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
• ² IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
• ³ Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid, Spain.
• ⁴ Universitat Pompeu Fabra, Barcelona, Spain.
• ⁵ Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.
• ⁶ Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
• ⁷ King's College London, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK.
• ⁸ NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK.
• ⁹ Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada.
• ¹⁰ Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
• ¹¹ ADx NeuroSciences NV, Ghent, Belgium.
• ¹² Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
• ¹³ Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
• ¹⁴ Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
• ¹⁵ Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.
• ¹⁶ UK Dementia Research Institute at UCL, London, UK.
• ¹⁷ Centro de Investigación Biomédica en Red Bioingeniería, Biomateriales y Nanomedicina, Madrid, Spain.
• ¹⁸ Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain. msuarez@barcelonabeta.org.
• ¹⁹ IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. msuarez@barcelonabeta.org.
• ²⁰ Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid, Spain. msuarez@barcelonabeta.org.
• ²¹ Servei de Neurologia, Hospital del Mar, Barcelona, Spain. msuarez@barcelonabeta.org.
• ²² Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden. kaj.blennow@neuro.gu.se.
• ²³ Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. kaj.blennow@neuro.gu.se.